TNFSF14 and bacterial pneumonia: On the basis of these results, we conclude that targeting the TNFSF14 signaling axis could revert TR-AM death in the aftermath of severe IAV-induced lung injury and thus prevent the transition to secondary bacterial pneumonia (Figure 7K).